Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: Systematic review and meta-synthesis

John Jackson, Sebastian Schneeweiss, Tyler J. VanderWeele, Deborah Blacker

Research output: Contribution to journalReview article

Abstract

Background: Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous thromboembolism, myocardial infarction, pneumonia, and hip fracture. Objectives: 1) Review robust epidemiologic evidence comparing mortality and medical event risk between FGAs and SGAs in older adults; 2) Quantify how much these medical events explain the observed mortality difference between FGAs and SGAs. Data sources: Pubmed and Science Citation Index. Study eligibility criteria, participants, and interventions: Studies of antipsychotic users that: 1) evaluated mortality or medical events specified above; 2) restricted to populations with a mean age of 65 years or older 3) compared FGAs to SGAs, or both to a non-user group; (4) employed a "new user" design; (5) adjusted for confounders assessed prior to antipsychotic initiation; (6) and did not require survival after antipsychotic initiation. A separate search was performed for mortality estimates associated with the specified medical events. Study appraisal and synthesis methods: For each medical event, we used a non-parametric model to estimate lower and upper bounds for the proportion of the mortality difference - comparing FGAs to SGAs - mediated by their difference in risk for the medical event. Results: We provide a brief, updated summary of the included studies and the biological plausibility of these mechanisms. Of the 1122 unique citations retrieved, we reviewed 20 observational cohort studies that reported 28 associations. We identified hip fracture, stroke, myocardial infarction, and ventricular arrhythmias as potential intermediaries on the causal pathway from antipsychotic type to death. However, these events did not appear to explain the entire mortality difference. Conclusions: The current literature suggests that hip fracture, stroke, myocardial infarction, and ventricular arrhythmias partially explain the mortality difference between SGAs and FGAs.

Original languageEnglish (US)
Article numbere105376
JournalPLoS One
Volume9
Issue number8
DOIs
StatePublished - Aug 20 2014
Externally publishedYes

Fingerprint

systematic review
Antipsychotic Agents
synthesis
Mortality
hip fractures
myocardial infarction
arrhythmia
Hip Fractures
stroke
Cardiac Arrhythmias
antipsychotics
Stroke
Myocardial Infarction
Observational Studies
Information Storage and Retrieval
Venous Thromboembolism
observational studies
cohort studies
PubMed
pneumonia

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults : Systematic review and meta-synthesis. / Jackson, John; Schneeweiss, Sebastian; VanderWeele, Tyler J.; Blacker, Deborah.

In: PLoS One, Vol. 9, No. 8, e105376, 20.08.2014.

Research output: Contribution to journalReview article

@article{0ecbe34a50c342ab90d88d25ce4dd031,
title = "Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: Systematic review and meta-synthesis",
abstract = "Background: Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous thromboembolism, myocardial infarction, pneumonia, and hip fracture. Objectives: 1) Review robust epidemiologic evidence comparing mortality and medical event risk between FGAs and SGAs in older adults; 2) Quantify how much these medical events explain the observed mortality difference between FGAs and SGAs. Data sources: Pubmed and Science Citation Index. Study eligibility criteria, participants, and interventions: Studies of antipsychotic users that: 1) evaluated mortality or medical events specified above; 2) restricted to populations with a mean age of 65 years or older 3) compared FGAs to SGAs, or both to a non-user group; (4) employed a {"}new user{"} design; (5) adjusted for confounders assessed prior to antipsychotic initiation; (6) and did not require survival after antipsychotic initiation. A separate search was performed for mortality estimates associated with the specified medical events. Study appraisal and synthesis methods: For each medical event, we used a non-parametric model to estimate lower and upper bounds for the proportion of the mortality difference - comparing FGAs to SGAs - mediated by their difference in risk for the medical event. Results: We provide a brief, updated summary of the included studies and the biological plausibility of these mechanisms. Of the 1122 unique citations retrieved, we reviewed 20 observational cohort studies that reported 28 associations. We identified hip fracture, stroke, myocardial infarction, and ventricular arrhythmias as potential intermediaries on the causal pathway from antipsychotic type to death. However, these events did not appear to explain the entire mortality difference. Conclusions: The current literature suggests that hip fracture, stroke, myocardial infarction, and ventricular arrhythmias partially explain the mortality difference between SGAs and FGAs.",
author = "John Jackson and Sebastian Schneeweiss and VanderWeele, {Tyler J.} and Deborah Blacker",
year = "2014",
month = "8",
day = "20",
doi = "10.1371/journal.pone.0105376",
language = "English (US)",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults

T2 - Systematic review and meta-synthesis

AU - Jackson, John

AU - Schneeweiss, Sebastian

AU - VanderWeele, Tyler J.

AU - Blacker, Deborah

PY - 2014/8/20

Y1 - 2014/8/20

N2 - Background: Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous thromboembolism, myocardial infarction, pneumonia, and hip fracture. Objectives: 1) Review robust epidemiologic evidence comparing mortality and medical event risk between FGAs and SGAs in older adults; 2) Quantify how much these medical events explain the observed mortality difference between FGAs and SGAs. Data sources: Pubmed and Science Citation Index. Study eligibility criteria, participants, and interventions: Studies of antipsychotic users that: 1) evaluated mortality or medical events specified above; 2) restricted to populations with a mean age of 65 years or older 3) compared FGAs to SGAs, or both to a non-user group; (4) employed a "new user" design; (5) adjusted for confounders assessed prior to antipsychotic initiation; (6) and did not require survival after antipsychotic initiation. A separate search was performed for mortality estimates associated with the specified medical events. Study appraisal and synthesis methods: For each medical event, we used a non-parametric model to estimate lower and upper bounds for the proportion of the mortality difference - comparing FGAs to SGAs - mediated by their difference in risk for the medical event. Results: We provide a brief, updated summary of the included studies and the biological plausibility of these mechanisms. Of the 1122 unique citations retrieved, we reviewed 20 observational cohort studies that reported 28 associations. We identified hip fracture, stroke, myocardial infarction, and ventricular arrhythmias as potential intermediaries on the causal pathway from antipsychotic type to death. However, these events did not appear to explain the entire mortality difference. Conclusions: The current literature suggests that hip fracture, stroke, myocardial infarction, and ventricular arrhythmias partially explain the mortality difference between SGAs and FGAs.

AB - Background: Observational studies have reported higher mortality among older adults treated with first-generation antipsychotics (FGAs) versus second-generation antipsychotics (SGAs). A few studies examined risk for medical events, including stroke, ventricular arrhythmia, venous thromboembolism, myocardial infarction, pneumonia, and hip fracture. Objectives: 1) Review robust epidemiologic evidence comparing mortality and medical event risk between FGAs and SGAs in older adults; 2) Quantify how much these medical events explain the observed mortality difference between FGAs and SGAs. Data sources: Pubmed and Science Citation Index. Study eligibility criteria, participants, and interventions: Studies of antipsychotic users that: 1) evaluated mortality or medical events specified above; 2) restricted to populations with a mean age of 65 years or older 3) compared FGAs to SGAs, or both to a non-user group; (4) employed a "new user" design; (5) adjusted for confounders assessed prior to antipsychotic initiation; (6) and did not require survival after antipsychotic initiation. A separate search was performed for mortality estimates associated with the specified medical events. Study appraisal and synthesis methods: For each medical event, we used a non-parametric model to estimate lower and upper bounds for the proportion of the mortality difference - comparing FGAs to SGAs - mediated by their difference in risk for the medical event. Results: We provide a brief, updated summary of the included studies and the biological plausibility of these mechanisms. Of the 1122 unique citations retrieved, we reviewed 20 observational cohort studies that reported 28 associations. We identified hip fracture, stroke, myocardial infarction, and ventricular arrhythmias as potential intermediaries on the causal pathway from antipsychotic type to death. However, these events did not appear to explain the entire mortality difference. Conclusions: The current literature suggests that hip fracture, stroke, myocardial infarction, and ventricular arrhythmias partially explain the mortality difference between SGAs and FGAs.

UR - http://www.scopus.com/inward/record.url?scp=84930431159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930431159&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0105376

DO - 10.1371/journal.pone.0105376

M3 - Review article

C2 - 25140533

AN - SCOPUS:84930431159

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e105376

ER -